Torsten Nielsen

VCH Clinical Title(s)

Director, UBC MD/PhD Program

Research Focus

Cancers

Degrees / Designations

MD/PhD, FRCPC

Contact Info

www.gpecdata.med.ubc.ca/torsten/

torsten@mail.ubc.ca

604-875-4111 x 66768

Biography

Dr. Torsten Nielsen was born in North Vancouver and inspired to be a cancer researcher by Terry Fox. He completed the MD/PhD training program at McGill and the Anatomical Pathology residency program at UBC, with additional training at Stanford and in England. He was appointed as an Assistant Professor at UBC and started his lab at VCHRI in 2003, and was promoted to full professor in 2012. Dr. Nielsen is also an affilated member of the departments of Orthopaedics and of Urological Sciences

News and Awards

A new state-of-the-art core facility sets the stage for advanced pathology research

Aug 4, 2021

Better diagnosis and treatment for young cancer patients

Apr 16, 2018

Publications

NPJ breast cancer -
Proteomics-derived basal biomarker DNA-PKcs is associated with intrinsic subtype and long-term clinical outcomes in breast cancer.
Asleh K, Riaz N, Cheng AS, Gao D, Leung SCY, Anurag M, Nielsen TO
Oncoimmunology -
The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine.
Stovgaard ES, Asleh K, Riaz N, Leung S, Gao D, Nielsen LB, Lænkholm AV, Balslev E, Jensen MB, Nielsen D, O Nielsen T
Trends in cancer -
Synovial Sarcoma Oncogenesis Revealed by Single-Cell Profiling.
Qiu A, Nielsen TO
Cancers -
Granulocyte Colony Stimulating Factor Expression in Breast Cancer and Its Association with Carbonic Anhydrase IX and Immune Checkpoints.
Chafe SC, Riaz N, Burugu S, Gao D, Leung SCY, Lee AF, Lee CH, Dedhar S, Nielsen TO
Journal of the National Cancer Institute -
Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group.
Nielsen TO, Leung SCY, Rimm DL, Dodson A, Acs B, Badve S, Denkert C, Ellis MJ, Fineberg S, Flowers M, Kreipe HH, Laenkholm AV, Pan H, Penault-Llorca FM, Polley MY, Salgado R, Smith IE, Sugie T, Bartlett JMS, McShane LM, Dowsett M, Hayes DF
The Journal of molecular diagnostics : JMD -
A Rapid and Cost-Effective Gene Expression Assay for the Diagnosis of Well-Differentiated and Dedifferentiated Liposarcomas.
Wang XQ, Wang XQ, Hsu ATYW, Goytain A, Ng TLT, Nielsen TO
Cancer treatment reviews -
Sarcomas: Immune biomarker expression and checkpoint inhibitor trials.
Zhu MMT, Shenasa E, Nielsen TO
Nature reviews. Cancer -
The epigenomics of sarcoma.
Nacev BA, Jones KB, Intlekofer AM, Yu JSE, Allis CD, Tap WD, Ladanyi M, Nielsen TO
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc -
Evaluation of glucocorticoid-induced TNF receptor (GITR) expression in breast cancer and across multiple tumor types.
Zhu MMT, Burugu S, Gao D, Yu J, Kos Z, Leung S, Horst BA, Nielsen TO
Neoplasia (New York, N.Y.) -
The FUS-DDIT3 Interactome in Myxoid Liposarcoma.
Yu JSE, Colborne S, Hughes CS, Morin GB, Nielsen TO

Torsten Nielsen

Biography

News and Awards

A new state-of-the-art core facility sets the stage for advanced pathology research

Better diagnosis and treatment for young cancer patients

Publications

Proteomics-derived basal biomarker DNA-PKcs is associated with intrinsic subtype and long-term clinical outcomes in breast cancer.

The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine.

Synovial Sarcoma Oncogenesis Revealed by Single-Cell Profiling.

Granulocyte Colony Stimulating Factor Expression in Breast Cancer and Its Association with Carbonic Anhydrase IX and Immune Checkpoints.

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group.

A Rapid and Cost-Effective Gene Expression Assay for the Diagnosis of Well-Differentiated and Dedifferentiated Liposarcomas.

Sarcomas: Immune biomarker expression and checkpoint inhibitor trials.

The epigenomics of sarcoma.

Evaluation of glucocorticoid-induced TNF receptor (GITR) expression in breast cancer and across multiple tumor types.

The FUS-DDIT3 Interactome in Myxoid Liposarcoma.

Are you a researcher?